143 related articles for article (PubMed ID: 38147642)
1. Factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer and venous thromboembolism.
Reyes EJ; Ruiz-Talero P; Arenas MA; Hernández-Flórez C; Muñoz OM
J Int Med Res; 2023 Dec; 51(12):3000605231219170. PubMed ID: 38147642
[TBL] [Abstract][Full Text] [Related]
2. Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer.
Dhamane AD; Shah S; Noxon V; Bruette R; Ferri M; Liu X; Jiang J; Luo X
Thromb Res; 2023 Apr; 224():52-59. PubMed ID: 36848784
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
4. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
[TBL] [Abstract][Full Text] [Related]
5. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
Kopolovic I; Lee AY; Wu C
Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
[TBL] [Abstract][Full Text] [Related]
6. Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.
van der Wall SJ; Klok FA; den Exter PL; Barrios D; Morillo R; Cannegieter SC; Jimenez D; Huisman MV
J Thromb Haemost; 2017 Jan; 15(1):74-79. PubMed ID: 28012224
[TBL] [Abstract][Full Text] [Related]
7. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis.
Amin A; Neuman WR; Lingohr-Smith M; Menges B; Lin J
Adv Ther; 2019 Jan; 36(1):59-71. PubMed ID: 30543037
[TBL] [Abstract][Full Text] [Related]
9. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
[TBL] [Abstract][Full Text] [Related]
10. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
Delate T; Charlu M; Zhu S; Pai A; Clark NP; Witt DM; King JM; King JB
Thromb Res; 2020 Dec; 196():367-370. PubMed ID: 32979674
[TBL] [Abstract][Full Text] [Related]
12. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
Shaw JR; Douketis J; Le Gal G; Carrier M
J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns of venous thromboembolism in a real-world population: the Q-VTE study cohort.
Tagalakis V; Patenaude V; Kahn SR; Suissa S
Thromb Res; 2014 Oct; 134(4):795-802. PubMed ID: 25135794
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
16. Active Cancer Patients Presenting to the Emergency Department with Acute Venous Thromboembolism: A Retrospective Cohort Study on Risks and Outcomes.
Ha EL; Castillo EM; Vilke GM; Oyama LC; Brennan JJ; Birring P; Shah S; Coyne CJ
J Emerg Med; 2021 Sep; 61(3):241-251. PubMed ID: 34215470
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
[TBL] [Abstract][Full Text] [Related]
19. Mortality risk analysis of asymptomatic and symptomatic venous thromboembolism in patients with metastatic colorectal cancer.
Bozkaya Y; Özdemir N; Erdem GU; Demirci NS; Yazıcı O; Hocazade C; Zengin N
J Cancer Res Ther; 2018; 14(6):1330-1335. PubMed ID: 30488852
[TBL] [Abstract][Full Text] [Related]
20. Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The CVRN VTE Study.
Fang MC; Fan D; Sung SH; Witt DM; Schmelzer JR; Williams MS; Yale SH; Baumgartner C; Go AS
Am J Med; 2019 Dec; 132(12):1450-1457.e1. PubMed ID: 31247183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
